Pharmaceutical Published Insights

Published Date : 12 Apr, 2026

Global GMP cell therapy consumables market growth is driven by increasing prevalence of chronic diseases like cancer. Cell therapy involves extracting cells from patient's/ donor's body and modifying them to fight against diseases. GMP consumables play a vital role in... View more

Published Date : 12 Apr, 2026

Cold sores, also known as fever blisters or oral herpes, are small, fluid-filled blisters that form around or inside the mouth. These are most commonly caused by the Herpes simplex virus type 1 (HSV-1). Global cold sore treatment market growth is driven by rising prev... View more

Published Date : 12 Apr, 2026

Leber congenital amaurosis (LCA) is a group of inherited retinal diseases causing severe visual impairment from birth. It is characterized by poor vision, nystagmus, and potentially blindness. LCA is typically caused due to mutations in genes responsible for photorece... View more

Published Date : 12 Apr, 2026

The Lenalidomide Drug Market is estimated to be valued at USD 14.08 Bn in 2025 and is expected to reach USD 22.04 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. Lenalidomideis an immunomo... View more

Published Date : 12 Apr, 2026

Global cosentyx drug market is estimated to be valued at USD 5.72 Bn in 2025, and is expected to reach USD 9.50 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032. Cosentyx (secukinumab) is a ... View more

Published Date : 12 Apr, 2026

The medical second opinion market is estimated to be valued at USD 8.30 Bn in 2025 and is expected to reach USD 24.18 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.5% from 2025 to 2032. The global medical se... View more

Published Date : 12 Apr, 2026

Global non opioid pain treatment market is estimated to be valued at USD 85.84  billion in 2025 and is expected to reach USD 155.01 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032. ... View more

Published Date : 12 Apr, 2026

The global gastric motility disorder drug market is estimated to be valued at USD 60.88 Bn in 2025 and is expected to exhibit a CAGR of 5.6% during the forecast period (2025-2032). Gastric motility disorder refers to conditions wherein the stomach takes more or less... View more

Published Date : 12 Apr, 2026

Global intravenous (IV) ibuprofen market is estimated to be valued at USD 7.96 Bn in 2026 and is expected to exhibit a CAGR of 7.4% during the forecast period (2025-2032). Intravenous (IV) ibuprofen is used for pain relief and fever reduction for several decades. As a... View more

Published Date : 12 Apr, 2026

Artificial Intelligence (AI) in healthcare is transforming medical imaging with the use of deep learning algorithms. One such application is the use of AI in ultrasound imaging. Ultrasound imaging is a commonly used imaging technique due to its non-invasive and cost-e... View more

Published Date : 12 Apr, 2026

Artificial intelligence (AI) has emerged as a transformative technology that is poised to revolutionize the pharmaceutical industry. By leveraging huge amounts of data and sophisticated algorithms, AI has the potential to help drug makers to accelerate drug discovery,... View more

Published Date : 12 Apr, 2026

The global uterine fibroids treatment drugs market is estimated to be valued at USD 2.02 Bn in 2025 and is expected to exhibit a CAGR of 8.1% during the forecast period (2025-2032). Uterine fibroids are non-cancerous tumors that grow in or on a woman's uterus. Sympt... View more

Published Date : 12 Apr, 2026

The global Sever's Disease Treatment Market is estimated to be valued at USD 1.41 Bn in 2025 and is expected to reach USD 2.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032. Sever's disea... View more

Published Date : 12 Apr, 2026

The paclitaxel injection market is estimated to be valued at USD 7.15 Bn in 2025 and is expected to reach USD 16.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032. The paclitaxel injectio... View more

Published Date : 12 Apr, 2026

The ethical pharmaceuticals market is estimated to be valued at USD 5.26 Bn in 2025 and is expected to reach USD 10.59 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032. The ethical pharmace... View more

Published Date : 12 Apr, 2026

The antihistamine drugs market is estimated to be valued at USD 101.74 Bn in 2025 and is expected to reach USD 167.80 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032. Antihistamine drugs are a ... View more

Published Date : 12 Apr, 2026

The incretin mimetics market is estimated to be valued at USD 23.84 Bn in 2025 and is expected to reach USD 33.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032. Incretin mimetics are a cl... View more

Published Date : 12 Apr, 2026

Complex chronic conditions refer to multiple chronic conditions occurring simultaneously in a person. These include conditions like diabetes, cancer, arthritis, COPD, Alzheimer's, and others. Factors such as rising geriatric population, increasing incidence of chronic... View more